In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?

Gonorrhea may become untreatable, and new treatment options are essential. We investigated the in vitro activity of the first fluoroketolide, solithromycin. Clinical Neisseria gonorrhoeae isolates and reference strains (n = 246), including the two extensively drug-resistant strains H041 and F89 and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Golparian, Daniel, Fernandes, Prabhavathi, Ohnishi, Makoto, Jensen, Jörgen S., Unemo, Magnus
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3346660/
https://ncbi.nlm.nih.gov/pubmed/22354296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00036-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados